Chinese cancer detection firm Burning Rock prices US IPO, ups target to $196m

Burning Rock Biotech, a cancer screening and therapy services provider in China, has filed to raise $196 million after pricing its US initial public offering (IPO) at a range of $13.50 and $15.50, according to an amended registration statement.